Heart Failure and Sudden Cardiac Death products
Explore Boston Scientific CRT-Ds and ICDs that feature HeartLogic, the first and only FDA-approved heart failure diagnostic that uses multiple sensors to track physiological trends, combines them into one composite index and sends proactive alerts of worsening heart failure.¹ Your extraordinary talent. Our extraordinary technology. Together, we can change the future of electrophysiology and heart failure management.
Our groundbreaking line of data-driven CRT-Ds gives you unprecedented insight and control, while offering an extraordinary, holistic approach to cardiac care. New technology may help you accurately predict heart failure events weeks in advance2 and control programming to maximize response long-term. All with the battery power to fully leverage device capabilities. In your hands, CRT-D devices with HeartLogic turn reactive treatment into proactive care.
Our groundbreaking line of data-driven ICDs offers an extraordinary, holistic approach to cardiac care and puts unprecedented insight, control and power in your hands. New technology may allow you to accurately predict heart failure events weeks in advance² and control programming to maximize response over the long-term. All with the battery power to fully leverage device capabilities. The future of heart failure management is here.
Remote Patient Management
The PREDICt RM Study, a retrospective analysis of nearly 40,000 patients, found that patients using the LATITUDE™ Remote Patient Management System had a 33% reduction in the risk of death and a 19% decrease in all-cause hospitalizations compared to those who were not remotely monitored.³